Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study

Lancet Oncology

Volumn 7, Issue 7, 2006, Pages 556-564

  Jiang, Zhong ^a   Chu, Peigou G ^b   Woda, Bruce A ^a   Rock, Kenneth L ^a   Liu, Qin ^a   Hsieh, Chung Cheng ^a   Li, Cuizhen ^a   Chen, Wengang ^b   Duan, Hai Ou ^c   McDougal, Scott ^c   Wu, Chin Lee ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; RNA BINDING PROTEIN; RNA BINDING PROTEIN IMP3; UNCLASSIFIED DRUG;

ADRENAL METASTASIS; ADULT; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MULTIVARIATE ANALYSIS; NEPHRECTOMY; OVARY METASTASIS; OVERALL SURVIVAL; PATIENT SELECTION; PERITONEUM METASTASIS; PLEURA METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROPERITONEAL CANCER; RISK FACTOR; SOFT TISSUE CANCER; TUMOR LOCALIZATION; VISCERAL METASTASIS; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RNA-BINDING PROTEINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33745264425     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70732-X     Document Type: Article

References (21)

1. Motzer R., Bander N., and Nanus D. Renal-cell carcinoma. N Engl J Med 335 (1996) 865-875
2. Cohen H., and McGovern F. Renal-cell carcinoma. N Engl J Med 353 (2005) 2477-2490
3. Chow W., Devesa S., Warren J., and Fraumeni Jr. J. Rising incidence of renal cell cancer in the United States. JAMA 281 (1999) 1628-1631
4. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
5. Tsui K., Shvarts O., Smith R., et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 163 (2000) 1090-1095
6. Sene A., Hunt L., McMahon R., and Carroll R. Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br J Urol 70 (1992) 125-134
7. Couillard D., and deVere White R. Surgery of renal cell carcinoma. Urol Clin North Am 20 (1993) 263-275
8. Thrasher J., and Paulson D. Prognostic factors in renal cancer. Urol Clin North Am 20 (1993) 247-262
9. Rabinovitch R., Zelefsky M., Gaynor J., and Fuks Z. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol 12 (1994) 206-212
10. Sandock D., Seftel A., and Resnick M. A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 154 (1995) 28-31
11. Lam J., Shvarts O., Leppert J., et al. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173 (2005) 1853-1862
12. Zhao H., Ljungber B., Grankvist K., et al. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med 3 (2006) e13
13. Nielsen J., Christiansen J., Lykke-Andersen J., et al. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19 (1999) 1262-1270
14. Mueller-Pillasch F., Pohl B., Wilda M., et al. Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev 88 (1999) 95-99
15. Monk D., Bentley L., Beechey C., et al. Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome. J Med Genet 39 (2002) 575-581
16. Mueller-Pillasch F., Lacher U., Wallrapp C., et al. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 14 (1997) 2729-2733
17. Wang T., Fan L., Watanabe Y., et al. L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. Br J Cancer 88 (2003) 887-894
18. Yantiss R., Woda B., Fanger G., et al. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 29 (2005) 188-195
19. Liao B., Hu Y., Herrick D., and Brewer G. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 280 (2005) 18517-18524
20. American Joint Committee on Cancer (AJCC). AJCC cancer staging manual. 6th edn. (2002), Springer-Verlag, New York
21. Yaniv K., Fainsod A., Kalcheim C., and Yisraeli J. The RNA-binding protein Vg1 RBP is required for cell migration during early neural development. Development 130 (2003) 5649-5661